Release of growth factors, cytokines and therapeutic molecules by hyaluronan-based hydrogels

Current Pharmaceutical Biotechnology

Volumn 13, Issue 7, 2012, Pages 1299-1305

  Peattie, Robert A ^a  

^a Tufts University   (United States)

Author keywords

Biomaterials; Cytokines; Growth factors; Hyaluronan; Hydrogels

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CARBOXYMETHYLCELLULOSE; CYANAMIDE; CYTOKINE; DRUG CARRIER; EPOXIDE; ESTER; GROWTH FACTOR; HEPARAN SULFATE; HORSERADISH PEROXIDASE; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; HYDRAZIDE DERIVATIVE; HYDROGEN PEROXIDE; HYDROXYPROPYLCELLULOSE; NUCLEOPHILE; POLYGLACTIN; UREA DERIVATIVE; ZINC ION;

ARTICLE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONTROLLED RELEASE FORMULATION; CROSS LINKING; DRUG DELIVERY SYSTEM; ESTERIFICATION; HUMAN; HYDROGEL; HYDROPHOBICITY; NONHUMAN; PROTEIN SECRETION; SPRAY DRYING;

EID: 84861145976     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112800624427     Document Type: Article

References (73)

1. Manuskiatti, W.; Mainach, H.I. Hyaluronic acid and skin: wound healing and aging. Int. J. Dermatol., 1996, 35(8), 539-544.
2. Paku, S.; Paweletz, N. First steps of tumor-related angiogenesis. Lab. Invest., 1991, 65(3), 334-346.
3. Carmeliet, P.; Ferreira, V.; Breier, G.; Pollefeyt, S.; Kieckens, L.; Gertsenstein, M.; Fahrig, M.; Vandenhoeck, A.; Harpal, K.; Eberhardt, C.; Declercq, C.; Pawling, J.; Moons, L.; Collen, D.; Risau, W.; Nagy, A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 1996, 380(6573), 435-439.
4. de Vries, C.; Escobedo, J.A.; Ueno, H.; Houck, K.; Ferrara, N.; Williams, L.T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, 1992, 255(5047), 989-991.
5. Gluzman-Poltorak, Z.; Cohen, T.; Herzog, Y.; Neufeld, G. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. J. Biol. Chem., 2000, 275(38), 18040-18045.
6. Wiig, M.; Abrahamsson, S.; Lundborg, G. Effects of hyaluronan on cell proliferation and collagen synthesis: a study of rabbit flexor tendons in vitro. AM. J. Hand Surg., 1996, 21(4), 599-604.
7. Chen, W.Y.; Abatangelo, G. Functions of hyaluronan in wound repair. Wound Repair Regen., 1999, 7(2), 79-89.
8. Hu, M.; Sabelman, E.E.; Lai, S.; Timek, E.K.; Zhang, F.; Hentz, V.R.; Lineaweaver, W.C. Polypeptide resurfacing method improves fibroblast's adhesion to hyaluronan strands. J. Biomed. Mater. Res., 1999, 47(1), 79-84.
9. Knudson, C.B.; Knudson, W. Hyaluronan and CD44: modulators of chondrocyte metabolism. Clin. Orthop. Relat. Res., 2004, 427, S152-162.
10. Kuo, J.W. Practical aspects of hyaluronan-based medical products. CRC Taylor & Francis; Boca Raton, FL. 2006.
11. Morra, M. Engineering of biomaterials surfaces by hyaluronan. Biomacromolecules, 2005, 6(3), 1205-1223.
12. Prestwich, G.D.; Kuo, J.W. Chemically-modified HA for therapy and regenerative medicine. Curr. Pharm. Biotech., 2008, 9(4), 242-245.
13. Luo, Y.; Prestwich, G.D. Novel biomaterials for drug delivery. Exp. Opin. Ther. Patent., 2001, 11(9), 1395-1410.
14. Oh, E.J.; Park, K.; Kim, K.S.; Kim, J.; Yang, J.A.; Kong, J.H.; Lee, M.Y.; Hoffman, A.S.; Hahn, S.K. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. J. Control. Release, 2009, 141(1), 2-12.
15. Shu, X.Z.; Liu, Y.; Palumbo, F.; Luo, Y.; Prestwich G.D. In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials, 2004, 25(7-8), 1339-1348.
16. Prestwich, G.D.; Shu, X.Z.; Liu, Y.; Cai, S.; Walsh, J.F.; Hughes, C.W.; Kirker, K.R.; Orlandi, R.R.; Park, A.H.; Thibeault, S.L.; Smith, M.E. Injectable synthetic extracellular matrices for tissue engineering and repair. Adv. Exp. Med. Biol., 2006, 585, 125-133.
17. Aly, M.N. Intra-articular drug delivery: a fast growing approach. Recent Pat. Drug Deliv. Formul., 2008, 2(3), 231-237.
18. Boateng, J.S.; Matthews, K.H.; Stevens, H.N.; Eccleston, G.M. Wound healing dressings and drug delivery systems: a review. J. Pharm. Sci., 2008, 97(8), 2892-2923.
19. Kuo, J.W.; Swann, D.A.; Prestwich, G.D. Chemical modification of hyaluronic acid by carbodiimides. Bioconjugate Chem., 1991, 2(4), 232-241.
20. Haney, A.F.; Doty, E. A barrier composed of chemically crosslinked hyaluronic acid (Incert) reduces postoperative adhesion formation. Fertil. Steril., 1998, 70(1), 145-151.
21. Pouyani, T.; Harbison, G.S.; Prestwich, G.D. Novel hydrogels of hyaluronic acid: synthesis, surface morphology, and solid-state NMR. J. Am. Chem. Soc., 1994, 116(17), 7515-7522.
22. Prestwich, G.D.; Marecak, D.M.; Marecek, J.F.; Vercruysse K.P.; Ziebell, M.R. Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives. J. Control. Release, 1998, 53(1-3), 93-103.
23. Vercruysse K.P.; Marecak, D.M.; Marecek, J.F.; Prestwich, G.D. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid. Bioconjug. Chem., 1997, 8(5), 686-694.
24. Band, P.A. In: The Chemistry, Biology and Medical Applications of Hyaluronan and its Derivatives, T.C. Laurent, ed.; Portland Press; London, 1998, p. 33-42.
25. Jackson, D.W.; Simon, T.M. Intra-articular distribution and residence time of Hylan A and B: a study in the goat knee. Osteoarthritis and Cartilage, 2006, 14(12), 1248-1257.
26. Campoccia, D.; Doherty, P.; Radice, M.; Brun, P.; Abatangelo, G.; Williams, D.F. Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials, 1998, 19(23), 2101-2127.
27. Anthony, E.T.; Syed, M.; Myers, S.; Moir, G.; Navsaria, H. The development of novel dermal matrices for cutaneous wound repair. Drug Discov. Today Ther. Strat., 2006, 3(1)(S), 81-86.
28. Nehrer, S.; Domayer, S.; Dorotka, R.; Schatz, K.; Bindreiter, U.; Kotz, R. Three-year clinical outcome after chondrocyte transplantation using a hyaluronan matrix for cartilage repair. Eur. J. Radiol., 2006, 57(1), 3-8.
29. Acunzo, G.; Guida, M.; Pellicano, M.; Tommaselli, G.A.; Sardo, A.D.; Bifulco, G.; Cirillo, D.; Nappi, C. Effectiveness of autocross-linked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic adhesiolysis: a prospective, randomized, controlled study. Hum. Reprod., 2003, 18(9), 1918-1921.
30. Guida, M.; Acunzo, G.; Di Spiezio Sardo, A.; Bifulco, G.; Piccoli, R.; Pellicano, M.; Cerrota, G.; Cirillo, D.; Nappi, C. Effectiveness of auto-crosslinked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic surgery: a prospective, randomized, controlled study. Hum. Reprod., 2004, 19(6), 1461-1464.
31. Brunelli, G.; Longinotti, C.; Bertazzo, C.; Pavesio, A.; Pressato, D. Adhesion reduction after knee surgery in a rabbit model by Hyaloglide, a hyaluronan derivative gel. J. Orthoped. Res., 2005, 23(6), 1377-1382.
32. Lindqvist, U.; Tolmachev, V.; Kairemo, K.; Astrom, G.; Jonsson, E.; Lindqvist, H. Elimination of stabilised hyaluronan from the knee joint in healthy men. Clin. Pharmacokinet., 2002, 41(8), 603-613.
33. Zhao, X.B.; Fraser, J.E.; Alexander, C.; Lockett, C.; White, B.J. Synthesis and characterization of a novel double crosslinked hyaluronan hydrogel. J. Mater. Sci. Mater. Med., 2002, 13(1), 11-16.
34. Johns, D.B.; Rodgers, K.E.; Donahue, W.D. Reduction of adhesion formation by postoperative administration of ionically cross-linked hyaluronic acid. Fertil. Steril., 1997, 68(1), 37-42.
35. Shu, X.Z.; Liu, Y.; Luo, Y.; Roberts, M.C.; Prestwich, G.D. Disulfide cross-linked hyaluronan hydrogels. Biomacromolecules, 2002, 3(6), 1304-1311.
36. Liu, Y.; Shu, X.Z.; Prestwich, G.D. Biocompatibility and stability of disulfide-crosslinked hyaluronan films. Biomaterials, 2005, 26(23), 4737-4746.
37. Ghosh, K.; Shu, X.Z.; Mou, R.; Lombardi, J.; Prestwich, G.D.; Rafailovich, M.H.; Clark, M.A.F. Rheological characterization of in situ cross-linkable hyaluronan hydrogels. Biomacromolecules, 2005, 6(5), 2857-2865.
38. Shu, X.Z.; Liu, Y.; Palumbo, F.; Prestwich, G.D. Disulfidecrosslinked hyaluronan-gelatin hydrogel films: a covalent mimic of the extracellular matrix for in vitro cell growth. Biomaterials, 2003, 24(21), 3825-3834.
39. Shu, X.Z.; Ahmad, S.; Liu, Y.; Prestwich, G.D. Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering. J. Biomed. Materiel. Res. A., 2006, 79(4), 902-912.
40. Fraser, J.R.; Laurent, T.C.; Laurent, U.B. Hyaluronan: its nature, distribution, functions and turnover., 1997, 242(1), 27-33.
41. Luo, Y; Kirker, K.R.; Prestwich, G.D. Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J. Control. Release, 2000, 69(1), 169-184.
42. Pike, D.B.; Cai, S.; Pomraning, K.R.; Firpo, M.A.; Fisher, R.J.; Shu, X.Z.; Prestwich, G.D.; Peattie, R.A. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials, 2006, 27(30), 5242-5251.
43. Lim, S.T.; Forbes, B.; Berry, D.J.; Martin, G.P.; Brown, M.B. In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits. Int. J. Pharm., 2002, 231(1), 73-82.
44. Prestwich, G.D.; Vercruysse, K.P. Profiles Therapeutic applications of hyaluronic acid and hyaluronan derivatives. Pharm. Sci. Tech. Today, 1998, 1(1), 42-43.
45. Na, K.; Kim, S.; Woo, D.G.; Sun, B.K.; Yang, H.N.; Chung, H.M.; Park, K.H. Combination material delivery of dexamethasone and growth factor in hydrogel blended with hyaluronic acid constructs for neocartilage formation. J. Biomed. Mat. Res. A, 2007, 83(3), 779-786.
46. Hahn, S.K.; Kim, S.J.; Kim, M.J.; Kim, D.H. Characterization and in vivo study of sustained-release formulation of human growth hormone using sodium hyaluronate. Pharm. Res., 2004, 21(8), 1374-1381.
47. Kim, S.J.; Hahn, S.K.; Kim, M.J.; Kim, D.H.; Lee, Y.P. Development of a novel sustained release formulation of recombinant human growth hormone using sodium hyaluronate microparticles. J. Control. Release, 2005, 104(2), 323-335.
48. Lim, S.T.; Martin, G.P.; Berry, D.J.; Brown, M.B. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J. Control. Release, 2000, 66(2-3), 281-292.
49. Ahsan, F.; Rivas, I.P.; Khan, M.A.; Torres Suarez, A.I. Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages. J. Control. Release, 2002, 79(1-3), 29-40.
50. Takeuchi, H.; Yamamoto, H.; Kawashima, Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev., 2001, 47(1), 39-54.
51. Surendrakumar, K.; Martin, G.P.; Hodgers, E.C.; Jansen, M.; Blair, J.A. Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. J. Control. Release, 2003, 91(3), 385-394.
52. Ohya, S.; Sonoda, H.; Nakayama, Y.; Matsuda, T. The potential of poly(N-isopropylacrylamide) (PNIPAM)-grafted hyaluronan and PNIPAM-grafted gelatin in the control of post-surgical tissue adhesions. Biomaterials, 2005, 26(6), 655-659.
53. Chung, H.J.; Lee, Y.; Park, T.G. Thermo-sensitive and biodegradable hydrogels based on stereocomplexed Pluronic multi-block copolymers for controlled protein delivery. J. Control. Release, 2008, 127(1), 22-30.
54. Hahn, S.K.; Oh, E.J.; Miyamoto, H.; Shimobouji, T. Sustained release formulation of erythropoietin using hyaluronic acid hydrogels crosslinked by Michael addition. Inter. J. Pharm., 2006, 322(1-2), 44-51.
55. Hahn, S.K.; Kim, J.S.; Shimobouji, T. Injectable hyaluronic acid microhydrogels for controlled release formulation of erythropoietin. J. Biomed. Material. Res. A, 2007, 80(4), 916-924.
56. Peattie, R.A.; Nayate, A.P.; Firpo, M.A.; Shelby, J.; Fisher, R.J.; Prestwich, G.D. Stimulation of in vivo angiogenesis by cytokineloaded hyaluronic acid hydrogel implants. Biomaterials, 2004, 25(14), 2789-2798.
57. Peattie, R.A.; Rieke, E.R.; Hewett, E.M.; Fisher, R.J.; Shu, X. Z; Prestwich, G.D. Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants. Biomaterials, 2006, 27(9), 1868-1875.
58. Kim, J.; Kim, I.S.; Cho, T.H.; Lee, K.B.; Hwang, S.J.; Tae, G.; Noh, I.; Lee, S.H.; Park, Y.; Sun, K. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials, 2007, 28(10), 1830-1837.
59. Yeo, Y.; Adil, M.; Bellas, E.; Astashkina, A.; Chaudhary, N.; Kohane, D.S. Prevention of peritoneal adhesions with an in situ crosslinkable hyaluronan hydrogel delivering budesonide. J. Control. Release, 2007, 120(3), 178-185.
60. Nomura, K.; Murakami, K.; Shozu, M.; Nakama, T.; Yui, N.; Inoue, M. Local application of danazol-loaded hyaluronic acid hydrogel to endometriosis in a rat model. Fertil. Steril., 2006, 85(S1), 1157-1167.
61. Wissink, M.J.; Beernink, R.; Poot, A.A.; Engbers, G.H.; Beugeling, T.; Van Aken, W.G.; Feijen, J. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. J. Control. Release, 2000, 64(1-3), 103-114.
62. Zhang, F.; Zhang, Z.; Lin, X.; Beenken, A.; Eliseenkova, A.V.; Mohammadi, M.; Linhardt, R.J. Compositional analysis of heparin/ heparan sulfate interacting with fibroblast growth factor fibroblast growth factor receptor complexes. Biochemistry, 2009, 48(35), 8379-8386.
63. Sun, B.; Chen, B.; Zhao, Y.; Sun, W.; Chen, K.; Zhang, J.; Wei, Z.; Xiao, Z.; Dai, J. Crosslinking heparin to collagen scaffolds for the delivery of human platelet-derived growth factor. J. Biomed. Material. Res. B, 2009, 91(1), 366-372.
64. Cai, S.; Liu, Y.; Shu, X.Z.; Prestwich, G.D. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials, 2005, 26(30), 6054-6067.
65. Liu, Y.; Cai, S.; Shu, X.Z.; Shelby, J.; Prestwich, G.D. Release of basic fibroblast growth factor from a crosslinked glycosaminoglycan hydrogel promotes wound healing. Wound Repair Regen., 2007, 15(2), 245-251.
66. Peattie, R.A.; Pike, D.B.; Yu, B.; Cai, S.; Shu, X.Z.; Firpo, M.A.; Fisher, R.J.; Prestwich, G.P. Effect of gelatin on heparin regulation of cytokine release from hyaluronan-based hydrogels. Drug Deliv., 2008, 15(6), 363-371.
67. Riley, C.M.; Fuegy, P.W.; Firpo, M.A.; Shu, X.Z.; Prestwich, G.D.; Peattie, R.A. Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels. Biomaterials, 2006, 27(35), 5935-5943.
68. Hosack, L.W.; Firpo, M.A.; Scott, J.A.; Prestwich, G.D.; Peattie, R.A. Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels. Biomaterials, 2008, 29(15), 2336-2347.
69. Elia, R.; Fuegy, P.W.; VanDelden, A.; Firpo, M.A.; Prestwich, G.D.; Peattie, R.A. Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels. Biomaterials, 2010, 31(17), 4630-4638.
70. Jha, A.K.; Yang, W.; Kim-Safran, C.B.; Farach-Carson, M.C.; Jia, X. Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release. Biomaterials, 2009, 30(6), 6964-6975.
71. Baumann, M.D.; Kang, C.E.; Stanwick, J.C.; Wang, Y.; Kim, H.; Lapitsky, Y.; Shoichet, M.S. An injectable drug delivery platform for sustained combination therapy. J. Control. Release, 2009, 138(3), 205-213.
72. Hirakura, T.; Yasugi, K.; Nemoto, T.; Sato, M.; Shimoboji, T.; Aso, Y.; Morimoto, N.; Akiyoshi, K. Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: new system for sustained delivery of protein with a chaperone-like function. J. Control. Release, 2010, 142(3), 483-489.
73. Lee, F.; Chung, J.E.; Kurisawa, M. An injectable hyaluronic acidtyramine hydrogel system for protein delivery. J. Control. Release, 2009, 134(3), 186-193.